121 related articles for article (PubMed ID: 37178151)
1. Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR.
Yan-Qiu M; Li JM; Wang ZQ; Xu DP; Huang MQ; Meng BB
J Asian Nat Prod Res; 2023 Dec; 25(12):1191-1204. PubMed ID: 37178151
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of oleanolic acid analogues targeting PDGF receptor inhibitors and their antitumor biological activities.
Meng YQ; Zhou Y; Li QW; Tong SM; Kuai ZY; Li XX
J Asian Nat Prod Res; 2021 Feb; 23(2):150-162. PubMed ID: 32102552
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-tumor activity of asiatic acid derivatives targeting VEGFR.
Meng YQ; Wang ZQ; Li JM; Xu DP; Meng BB; Huang MQ
J Asian Nat Prod Res; 2023 Dec; 25(12):1205-1216. PubMed ID: 37081794
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and anti-tumor activity of derivatives of ring A and C-28 of asiatic acid.
Yan-Qiu M; Meng BB; Xu DP; Wang ZQ; Li JM; Huang MQ
J Asian Nat Prod Res; 2024 Apr; 26(4):497-509. PubMed ID: 37670663
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
Meng YQ; Feng CQ; Zhang LF; Zhang M; Zhao N
Yao Xue Xue Bao; 2015 Apr; 50(4):469-74. PubMed ID: 26223130
[TBL] [Abstract][Full Text] [Related]
8. Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors.
Aouad MR; Al-Mohammadi HM; Al-Blewi FF; Ihmaid S; Elbadawy HM; Althagfan SS; Rezki N
Bioorg Chem; 2020 Jan; 94():103446. PubMed ID: 31791685
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis,
Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G
Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors.
Wang J; Huang L; Chen X; Yuan Y; Sun J; Yang M
Chem Pharm Bull (Tokyo); 2022; 70(9):637-641. PubMed ID: 36047235
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line.
Tuncay S; Senol H; Guler EM; Ocal N; Secen H; Kocyigit A; Topcu G
Med Chem; 2018; 14(6):617-625. PubMed ID: 29473521
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities.
Tang L; Zhang Y; Xu J; Yang Q; Du F; Wu X; Li M; Shen J; Deng S; Zhao Y; Xiao Z; Chen Y
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771080
[TBL] [Abstract][Full Text] [Related]
15. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives.
Liu Q; Liu H; Zhang L; Guo T; Wang P; Geng M; Li Y
Eur J Med Chem; 2013 Jun; 64():1-15. PubMed ID: 23639650
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of VEGFR-2 inhibitors based on oleanolic acid moiety.
Song YL; Zhang PB; Tong RJ; Li L; Meng YQ
J Asian Nat Prod Res; 2021 Feb; 23(2):176-188. PubMed ID: 31888388
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors.
Kumar A; Kumar B; Bhatia R
Assay Drug Dev Technol; 2023 Jul; 21(5):222-233. PubMed ID: 37439798
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
20. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
